Findings compared with family members of patients with non-COVID-19 acute respiratory distress syndrome

Among U.S. adult prescription opioid users, 9.2 percent also prescribed dual anxiolytic/sedative therapy

Less than one-quarter of older adults report they would want to take it

People who survived the first 30 days of SARS-CoV-2 had increased risk for anxiety, depression, stress and adjustment, sleep, and substance use disorders

Surveillance data show 20.9 percent aged 12 to 17 years had major depressive episode; 18.8 percent seriously considered attempting suicide

Odds ratios varied from 0.18 for family psychoeducation alone to 0.63 for community-based interventions involving family

Decreases in distress and perceived risks for infection, hospitalization, and death reported by those receiving at least one dose of vaccine

Incidence of overall mortality was also highest for untreated patients with hepatitis C virus

Possible risks from taking the drug include accidental poisoning and addiction

Combinations using an antagonist of presynaptic α2-autoreceptors may be an option for depression that does not respond to monotherapy